SHARE
COPY LINK

INNOVATION

US tourism to Norway still up on ‘Frozen effect’

Two years after the Disney hit Frozen put Norway firmly on the tourism map, the number of Americans flocking to experience the picturesque homeland of the Snow Queen Elsa and her kooky sister Anna continues to climb.

US tourism to Norway still up on 'Frozen effect'
The stunning Norwegian landscape in Disney's Frozen. Photo: The Walt Disney Company
“We are hoping that the US market continues to grow this year,” Mona Raa Ravndal from Innovation Norway, told the country’s TV2 broadcaster. “Compared to this time last year we are a little ahead.” 
 
Norwegian Airlines is reporting a 30 percent jump in the number of American tourists flying to Norway on its planes this year compared to the first half of last year. 
 
Innovation Norway signed a partnership deal with Disney to promote the film in May 2013, six months before its release, a deal which has proven to be a brilliant move, given the film’s huge success, grossing $400m by July last year. 
 
Disney’s cartoonists were sent on a two-week trip to Norway to soak in the sights of Norway and the film includes several Norwegian landmarks, including the Akershus Fortress in Oslo, the Nidaros Cathedral in Trondheim, and Bryggen in Bergen. 
 
The landscape around the kingdom of Arendelle was inspired by the narrow Nærøyfjord. 
 
This year’s growth comes on top of a 31 percent leap in the number nights spent by US guests in Norwegian hotels from 2013 to 2014.
 
The increase in US tourism has also been helped by the strong dollar, which has made Norway the most affordable it has been for Americans since 2002.  
 
Norwegian Airlines also in 2013 started offering direct flights between Norway and the US at reasonable rates.
 
“We are now flying about as many Americans as Norwegians to and from the US West coast,” Norwegian’s spokesman Lasse Sandakerveien-Nielsen told the channel. “On the New York-Bergen,  route, we are flying more Americans than people from Bergen.” 
 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

INNOVATION

Danish companies invent like never before

Recent years have seen unrivalled levels of productivity from Danish inventors.

Danish companies invent like never before
Novozymes' lab in Bagsværd. File photo: Mads Claus Rasmussen/Ritzau Scanpix

An enzyme that breaks down dead cells in the stomachs of chickens so that they don’t need as much feed.

An algorithm that stabilizes the swaying of a wind turbine so that it can be built with a little less steel.

These are examples of products that two Danish companies, Novozymes and Vestas, have developed and been granted patents for.

Danish companies are now among the most active in developing new products, according to a report published on Tuesday by the European Patent Office. In the report, Denmark was listed as number 3, after Holland and Switzerland.

In 2018, Danish companies applied for 2,390 patents in Europe, a 14.4 percent increase compared to the year before, and the highest amount Danish companies have ever applied for in one year, the report stated.

The Confederation of Danish Industry (Dansk Industri, DI), a private interest organization made up of approximately 10,000 Danish companies within manufacturing, service and trade, said the report reflects an investment on developing new ideas and transforming these ideas into real solutions.

“Danish companies are highly innovative. They are willing to invest large sums of money in order to be the first ones to come up with new solutions,” DI’s head consultant Lars Holm Nielsen said.

“The largest companies invest a lot of money in research and development, but there are also many small and medium-sized companies that are ahead in their respective fields when it comes to the development of new products,” Nielsen added.

Several of Denmark’s largest companies are amongst the most active in finding and developing new ideas. Last year, Novozymes was at the top with 192 patent applications. Vestas, Novo Nordisk, and Oticon were all close behind.

Claus Crone Fuglsang, research director at Novozymes, said that patents are crucial if the company is to continue to develop new products.

“Novozymes is a company that is driven by innovation. Patents ensure that the company finds a legitimate market for the products we develop. Patents also help us to maintain earnings to cover the costs of the development process,” Fuglsang said.

“Without patents, technology makes it very easy for others to copy our products. We have to make sure that we that we are compensated for the costs of research and development,” he added.

READ ALSO: Four ways Copenhagen is leading on innovation

SHOW COMMENTS